SCM
MANE

Suvretta Capital Management’s Veradermics Inc MANE Stock Holding History

Suvretta Capital Management’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$513M Hold
4,168,970
– – 9.37% 2
2026
Q1 		$263M Buy
+4,168,970
New +$210M 6.72% 2

Other funds holding MANE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Suvretta Capital Management's MANE Position: Q2 2026 in Review

Suvretta Capital Management held its Veradermics Inc (MANE) position steady in Q2 2026 at 4,168,970 shares worth $513M. The position accounts for 9.37% of the portfolio, ranked #2.

Suvretta Capital Management first reported a position in MANE in Q1 2026 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

  • Suvretta Capital Management held 4,168,970 shares of Veradermics Inc worth $513M as of Q2 2026.
  • Suvretta Capital Management left its Veradermics Inc share count unchanged in Q2 2026.
  • Veradermics Inc made up 9.37% of Suvretta Capital Management's portfolio in Q2 2026, its #2 holding.
  • Suvretta Capital Management first reported a position in Veradermics Inc in Q1 2026 and has held it in 2 quarters since.
  • 164 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on Suvretta Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.